Search

Your search keyword '"Alamillo J"' showing total 140 results

Search Constraints

Start Over You searched for: Author "Alamillo J" Remove constraint Author: "Alamillo J"
140 results on '"Alamillo J"'

Search Results

1. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

4. Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions

5. P59.03 Comparison of Two RNA-Based Platforms for Detection of Fusions and Met Splicing Variant in Non Small Cell Lung Cancer Samples

11. Copy Number Gains (CNGs) of Clinically Relevant Genes in Advanced NSCLC Patients

12. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: Results from the ETOP Lungscape Project

13. P2.01-56 Copy Number Gains (CNGs) of Clinically Relevant Genes in Advanced NSCLC Patients

17. P1.13-01 Anti-EGF Antibodies Increase the Effect of ALK and MEK Inhibitors in ALK and KRAS NSCLC and CRC Cell Lines

19. P2.02-014 Simultaneous Gene Profiling of Advanced NSCLC: Single-Molecule Quantification of DNA and RNA by nCounter3D™ Technology

20. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer

21. The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial

22. Lung adenocarcinoma. Molecular-Based Decision Making for Personalized Cancer Management

23. Influence of BRCA1 and astrocyte elevated gene-1 as identified by multiplex target profiling of gene expression on outcome in erlotinib-treated non-small-cell lung cancer patients harboring EGFR mutations

25. 3120 Analysis of gene expression in the re-replication pathway and selective blockade with checkpoint inhibitors as a therapeutic option in NSCLC

29. Differential expression of BRCA1 and genes involved in the nuclear factor kappa B (NFκB) and notch signalling pathways in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) patients (p).

30. Identification of AEG-1 and BARD1 as predictors of erlotinib outcome in EGFR-mutant non-small cell lung cancer (NSCLC) by NanoString multiple target profiling.

31. The nuclear factor kB (NFkB) and Notch signaling pathways and BRCA1 mRNA expression in stage IV non-small cell lung cancer (NSCLC) patients (p).

32. Initial detection of the double epidermal growth factor receptor (EGFR) mutation (L858R or deletion in exon 19 [del 19] plus T790M) in non-small cell lung cancer (NSCLC) patients (p) with brain metastases (mets) and the influence of first-line chemotherapy on outcome to erlotinib.

33. Mutations of the catalytic subunit a of PI3K (PIK3CA) in erlotinib-treated non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations.

34. Gene expression during water stress

39. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations

41. Effect of first-line treatment and CHFR and 14–3-3σ methylation status on survival to second-line chemotherapy or EGFR tyrosine kinase inhibitors (TKIs) in stage IV non-small-cell lung cancer (NSCLC)

47. Constitutive expression of small heat shock proteins in vegetative tissues of the resurrection plant craterostigma plantagineum

49. Urate-mediated regulation of urate oxidase in Chlamydomonas reinhardtii.

Catalog

Books, media, physical & digital resources